Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, P.R. China
Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Qingdao 266237, P.R. China
Curr Med Chem. 2020;27(36):6244-6273. doi: 10.2174/0929867326666190618153950.
Microorganisms obtained from the deep sea are a rich source of marine natural products with distinctive chemical structures and bioactivities. In this review, we will provide a retrospective of outstanding research within the scope of deep-sea (≥1000 m) microbial natural products, which has produced up to 442 compounds by the end of 2017. Approximetely, 60% of these structures have demonstrated various biological activities with more than 30% showing cytotoxic function. In this review, we particularly summarize those successful research on secondary metabolites produced by deep-sea derived microorganisms with inclusion of structural characteristics, biological activities, together with biogenetic origins and taxonomic features of the source microorganisms, from which, we expect to provide more comprehensive understanding of small molecules obtained from deep-sea environment and benefit the ongoing scholarly endeavors in the search for novel pharmaceutical agents from the deep-sea derived microorganisms.
从深海中获得的微生物是海洋天然产物的丰富来源,具有独特的化学结构和生物活性。在这篇综述中,我们将回顾深海(≥1000 米)微生物天然产物领域的杰出研究成果,截至 2017 年底,已产生了 442 种化合物。这些结构中约有 60%表现出各种生物活性,超过 30%显示出细胞毒性。在这篇综述中,我们特别总结了深海来源微生物产生的次生代谢产物的成功研究,包括结构特征、生物活性,以及来源微生物的生物发生和分类特征,希望能更全面地了解深海环境中获得的小分子,并有助于从深海来源的微生物中寻找新型药物制剂的持续学术研究。